Direct Activation of Pro-Matrix Metalloproteinase-2 by Leukolysin/Membrane-type 6 Matrix Metalloproteinase/Matrix Metalloproteinase 25 at the Asn109-Tyr Bond

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6758-6762

  Nie, Jing ^a   Pei, Duanqing ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; GELATINASE A; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 25; MATRIX METALLOPROTEINASE 6; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN TUMOR; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME PURIFICATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; WESTERN BLOTTING; ZYMOGRAPHY;

AMINO ACID SEQUENCE; CATALYTIC DOMAIN; CELL LINE; ENZYME ACTIVATION; ENZYME PRECURSORS; GELATINASES; HUMANS; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; TRANSFECTION;

EID: 0142219888     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Zucker, S., Cao, J., and Chen, W. T. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene, 19: 6642-6650, 2000.
2. Chambers, A. F., and Matrisian, L. M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst., 89: 1260-1270, 1997.
3. Massova, I., Kotra, L. P., Fridman, R., and Mobashery, S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J., 12: 1075-1095, 1998.
4. Corcoran, M. L., Hewitt, R. E., Kleiner, D. E., Jr., and Stetler-Stevenson, W. G. MMP-2: expression, activation and inhibition. Enzyme Protein, 49: 7-19, 1996.
5. Sang, Q. X. Complex role of matrix metalloproteinases in angiogenesis. Cell Res., 8: 171-177, 1998.
6. Birkedal-Hansen, H., Moore, W. G., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J. A. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med., 4: 197-250, 1993.
7. Werb, Z., Vu, T. H., Rinkenberger, J. L., and Coussens, L. M. Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS, 107: 11-18, 1999.
8. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (Lond.), 370: 61-65, 1994.
9. Seiki, M. Membrane-type matrix metalloproteinases. APMIS, 107: 137-143, 1999.
10. Nakahara, H., Howard, L., Thompson, E. W., Sato, H., Seiki, M., Yeh, Y., and Chen, W. T. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. USA, 94: 7959-7964, 1997.
11. Kang, T., Nagase, H., and Pei, D. Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network. Cancer. Res., 62: 675-681, 2002.
12. Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., and Tryggvason, K. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. USA, 97: 4052-4057, 2000.
13. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Robey, P. G., Poole, A. R., Pidoux, I., Ward, J. M., and Birkedal-Hansen, H. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell, 99: 81-92, 1999.
14. Strongin, A. Y., Marmer, B. L., Grant, G. A., and Goldberg, G. I. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem., 268: 14033-14039, 1993.
15. Strongin, A. Y., Collier, I., Bannikov, G., Manner, B. L., Grant, G. A., and Goldberg, G. I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem., 270: 5331-5338, 1995.
16. Pei, D. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell Res., 9: 291-303, 1999.
17. Velasco, G., Cal, S., Merlos-Suarez, A., Fernando, A. A., Alvarez, S., Nakano, A., Arribas, J., and Lopez-Otin, C. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res., 60: 877-882, 2000.
18. Kojima, S., Itoh, Y., Matsumoto, S., Masuho, Y., and Seiki, M. Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett., 480: 142-146, 2000.
19. Pei, D. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J. Biol. Chem., 274: 8925-8932, 1999.
20. Takino, T., Sato, H., Shinagawa, A., and Seiki, M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem., 270: 23013-23020, 1995.
21. Will, H., and Hinzmann, B. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem., 231: 602-608, 1995.
22. Kang, T., Yi, J., Guo, A., Wang, X., Overall, C., Jiang, W., Elde, R., Borregaard, N., and Pei, D. Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils. J. Biol. Chem., 276: 21960-21968, 2001.
23. English, W. R., Velasco, G., Stracke, J. O., Knauper, V., and Murphy, G. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25). FEBS Lett., 491: 137-142, 2001.
24. Hernandez-Barrantes, S., Toth, M., Bernardo, M. M., Yurkova, M., Gervasi, D. C., Raz, Y., Sang, Q. A., and Fridman, R. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem., 275: 12080-12089, 2000.
25. Pei, D., and Weiss, S. J. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem., 271: 9135-9140, 1996.
26. Pei, D., and Yi, J. A high-level mammalian expression system based on the Madin-Darby canine kidney cell line. Protein Expr. Purif., 13: 277-281, 1998.
27. Knauper, V., Wilhelm, S. M., Seperack, P. K., DeClerck, Y. A., Langley, K. E., Osthues, A., and Tschesche, H. Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem. J., 295: 581-586, 1993.
28. Pei, D., and Weiss, S. J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature (Lond.), 375: 244-247, 1995.
29. Will, H., Atkinson, S. J., Butler, G. S., Smith, B., and Murphy, G. The soluble CAT of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J. Biol. Chem., 271: 17119-17123, 1996.
30. Nagase, H., Fields, C. G., and Fields, G. B. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). J. Biol. Chem., 269: 20952-20957, 1994.
31. Knight, C. G., Willenbrock, F., and Murphy, G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett., 296: 263-266, 1992.
32. Itoh, Y., Takamura, A., Ito, N., Maru, Y., Sato, H., Suenaga, N., Aoki, T., and Seiki, M. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J., 20: 4782-4793, 2001.